sotalol   Click here for help

GtoPdb Ligand ID: 7297

Synonyms: Betapace® | MJ-1999
Approved drug
sotalol is an approved drug (FDA (1992))
Compound class: Synthetic organic
Comment: Sotalol is a β-blocker & potassium channel blocker.
Marketed formulations may contain sotalol hydrochloride (PubChem CID 66245).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 86.81
Molecular weight 272.12
XLogP 1.05
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
Isomeric SMILES CC(NCC(c1ccc(cc1)NS(=O)(=O)C)O)C
InChI InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3
InChI Key ZBMZVLHSJCTVON-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Used to treat cardiac arrythymias.
In October 2014, Solytize® became the first oral preparation containing sotalol hydrochloride to gain approval for the treatment of life-threatening ventricular arrhythmias (US FDA approval).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
This drug antagonises cardiac β-adrenoceptors. It also blocks inward potassium channel currents, prolonging repolarisation and slowing conduction at the atrioventricular (AV) node. See the DrugBank link for further details.
External links Click here for help